Semaglutide, more commonly known as Ozempic, can do more than help with weight loss. A new clinical trial shows it helps treat poor blood flow in diabetic patients, which could otherwise lead to arm and leg amputations. Health reporter Katherine Ward has more on the Canadian connection.